Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan

NCT05132127

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • Investigational Site Number 3920005 Ishikawa, Japan
  • Investigational Site Number 3920004 Kanagawa, Japan
  • Investigational Site Number 3920003 Osaka, Japan
  • Investigational Site Number 3920002 Saitama, Japan
View Trial Details
Completed

A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT02500407

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Sansum Medical Clinic, Inc. Santa Barbara, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease

NCT03653247

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Investigational Site Number 101 Bethesda, Maryland, United States
View Trial Details
Completed

Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT04045795

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • ~Banner MD Anderson Cancer Center Site Number : 8400005 Gilbert, Arizona, United States
  • City of Hope Site Number : 8400002 Duarte, California, United States
  • Gabrail Cancer Center Site Number : 8400001 Canton, Ohio, United States
  • Investigational Site Number : 0360002 Blacktown, New South Wales, Australia
View all 14 locations
View Trial Details
Completed

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

NCT04000282

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • City of Hope Site Number : 8400002 Duarte, California, United States
  • Dana Farber Cancer Institute Site Number : 8400003 Boston, Massachusetts, United States
  • Mayo Clinic of Rochester Site Number : 8400005 Rochester, Minnesota, United States
  • UNC Chapel Hill Site Number : 8400006 Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn

NCT03755128

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN), Erythroblastosis, Fetal, +8 more
Locations
  • Columbia University Medical Center New York, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • UPMC Pittsburgh, Pennsylvania, United States
View all 18 locations
View Trial Details

Related conditions